The Multicenter, Phase II Prospective Study of Paclitaxel Plus Capecitabine as First-Line Chemotherapy in Advanced Gastric Carcinoma | |
Gong, Jifang; Hu, Bing; Zhang, Xiaotian; Zhang, Fengchun; Zhang, Jun; Xu, Nong e; Fan, Qingxia; Bai, Yuxian; Jiao, Shunchang; Wang, Jinwan | |
2014 | |
卷号 | 19期号:2页码:173-174 |
ISSN号 | 1083-7159 |
DOI | 10.1634/theoncologist.2013-0137 |
URL标识 | 查看原文 |
收录类别 | SCIE |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6682482 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Gong, Jifang,Hu, Bing,Zhang, Xiaotian,et al. The Multicenter, Phase II Prospective Study of Paclitaxel Plus Capecitabine as First-Line Chemotherapy in Advanced Gastric Carcinoma[J],2014,19(2):173-174. |
APA | Gong, Jifang.,Hu, Bing.,Zhang, Xiaotian.,Zhang, Fengchun.,Zhang, Jun.,...&Shen, Lin.(2014).The Multicenter, Phase II Prospective Study of Paclitaxel Plus Capecitabine as First-Line Chemotherapy in Advanced Gastric Carcinoma.,19(2),173-174. |
MLA | Gong, Jifang,et al."The Multicenter, Phase II Prospective Study of Paclitaxel Plus Capecitabine as First-Line Chemotherapy in Advanced Gastric Carcinoma".19.2(2014):173-174. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论